Intensive immunosuppressive therapy for endogenous lipoid pneumonia associated with rheumatoid arthritis

Endogenous lipoid pneumonia is an uncommon inflammatory pulmonary disease that is caused by lipids from an endogenous source, the treatment for which has not been established. We report the first case of endogenous lipoid pneumonia presenting as lung consolidation and which was associated with rheum...

Full description

Saved in:
Bibliographic Details
Published in:Modern rheumatology 2018-11, Vol.28 (6), p.1044-1048
Main Authors: Morita, Hiroko, Arai, Satoko, Kurasawa, Kazuhiro, Okada, Harutsugu, Tanaka, Ayae, Yamazaki, Ryutaro, Owada, Takayoshi, Maezawa, Reika
Format: Article
Language:English
Subjects:
Arthritis, Rheumatoid - complications
Bronchoalveolar Lavage - methods
Bronchoscopy - methods
Cholestasis - diagnosis
Cholestasis - drug therapy
Cholestasis - etiology
Cyclophosphamide - administration & dosage
Dose-Response Relationship, Drug
Humans
Immunosuppressive Agents - administration & dosage
Lipoid pneumonia
Lung - diagnostic imaging
Lung - pathology
Male
Methylprednisolone - administration & dosage
Middle Aged
Pneumonia - diagnosis
Pneumonia - drug therapy
Pneumonia - etiology
Pulmonary involvement
Rheumatoid arthritis
Tomography, X-Ray Computed
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endogenous lipoid pneumonia is an uncommon inflammatory pulmonary disease that is caused by lipids from an endogenous source, the treatment for which has not been established. We report the first case of endogenous lipoid pneumonia presenting as lung consolidation and which was associated with rheumatoid arthritis. Treatment was successful with intensive immunosuppressive therapy. When a physician finds lung consolidation in a patient with active rheumatic disease, lipoid pneumonia should be considered.
ISSN:1439-7595
1439-7609
DOI:10.1080/14397595.2016.1193270